Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study
Lynn Chollet‐Hinton(University of North Carolina at Chapel Hill), Melissa A. Troester(University of North Carolina at Chapel Hill), Andrew F. Olshan(University of North Carolina at Chapel Hill), Mary B. Bell(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University), Chiu-Kit Tse(University of North Carolina at Chapel Hill), Yang Claire Yang(University of North Carolina at Chapel Hill)
Cited by 138
Related Papers
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991